Cerberus Capital – The Diabolical Purveyors of Cheap Food and Expensive Pharmaceuticals

‘What if I told you the people creating, pricing and selling us our groceries are the same people in-charge of researching, developing, dispensing, and promoting our most popular prescription medications?
Is it just bad luck or coincidence that in 2017 an American has a heart attack every single 34 seconds, while another has a stroke every 40 seconds? Is it just dumb-luck that over 37.7% of the U.S. population is currently obese, while 34% of the U.S. population has high blood pressure, with over 23.4 million Americans now suffering from diabetes?
Well, these are most likely not coincidences, as the heart disease sector of the U.S. healthcare market is already extremely lucrative—raking in over $318 billion in 2016—while currently rapidly expanding into the global marketplace. In fact, worldwide in 2010, the estimated cost of cardiovascular disease was $863 billion, and it’s estimated to rise to $1044 billion by 2030.
With numbers of this magnitude, it shouldn’t take long to understand why a group of greedy investors might want a piece of this tremendous growth. So badly, that it might even outweigh their moral burdens pertaining to how many people would have to die for them to do so.’
Read more: Cerberus Capital – The Diabolical Purveyors of Cheap Food and Expensive Pharmaceuticals